WUSTL Key gets updated
The WUSTL Key will take on a different look Tuesday, March 18, as part of efforts to update WashU branding. Log-in details and access will remain the same.
William D. Owens, MD, professor emeritus of anesthesiology, 85
William D. Owens, MD, a highly regarded professor emeritus of anesthesiology and former head of the Department of Anesthesiology at Washington University School of Medicine, died of cancer Jan. 3.
Floyd Bloom, emeritus trustee, 88
Floyd E. Bloom, MD, an honorary emeritus trustee at Washington University in St. Louis, died Jan. 8. He was 88. A WashU Medicine alumnus, he made groundbreaking contributions to modern neuroscience.
Emergency communication test March 11
WashU plans to test its emergency communication system at 8:55 a.m. Tuesday, March 11. (An alternative date is set for March 14 if needed.) The test ensures WashU can effectively communicate with the community in an emergency.
Two WashU Medicine projects compete in STAT Madness
Online voting is open for the top biomedical innovation or discovery of 2024. The first round ends early Monday, March 10.
Register for spring wellness challenge
Registration is now open for the next WashU fitness initiative, Star Trak, a six-week opportunity focused on increased movement and energy. The challenge begins March 17.
Martin to speak at Anti-Defamation League event
Chancellor Andrew D. Martin will be one of the keynote speakers at the Anti-Defamation League’s “Never is Now” summit, an annual gathering focused on combating antisemitism and hate, Monday, March 3.
Nominate staff for Distinguished Honor Awards
Nominations are open for WashU’s Distinguished Honor Awards, which recognize staff members’ important contributions. The deadline is March 15.
Study highlights barriers to genetic testing for Black children
A recent study by WashU Medicine researchers found Black children were about half as likely as white children to obtain genetic testing ordered by their neurologists.
Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.
View More Stories